Introduction
Methods
Patient selection
CMR protocol
CMR post-processing
Statistical analysis
Results
Demographics and outcomes
Mean ± SD or N (%) | |
---|---|
Age (years) | 14 ± 5 |
Height (m) | 1.46 ± 0.18 (n = 65) |
Weight (kg) | 50.1 ± 17.8 |
BSA (m2) | 1.41 ± 0.32 |
Ambulatory | 17(26%) |
Medications at baseline CMR | |
Corticosteroid | 33 (50%) |
Angiotensin converting enzyme inhibitor | 33 (50%) |
Beta blocker | 24 (36%) |
Aldosterone inhibitor | 4 (6%) |
Angiotensin receptor blocker | 6(9%) |
LVEF (%) | 54.3 ± 9.7 |
LVEDV (mL) LVEDVI (mL/m2) | 93 ± 42 67 ± 20 (n = 65) |
LVESV (mL) LVESVI (mL/m2) | 45 ± 33 32 ± 17 (n = 65) |
LV mass (g) Indexed LV mass (g/m2) | 71 ± 27 49 ± 13 (n = 65) |
Global native T1 (ms) | 1048 ± 44 (n = 54) |
Global εcc (%) | − 14.1 ± 3.5 (n = 64) |
Presence of late gadolinium enhancement (LGE) | 44 (70%) |
Full width half maximum quantification of LGE (%) | 21.3 ± 18.4 (n = 60) |
GSS = 0 | 19 (30%) |
GSS = 1 | 12 (19%) |
GSS = 2 | 12 (19%) |
GSS = 3 | 13 (21%) |
GSS = 4 | 7 (11%) |
Native T1 and strain predict the presence/absence and extent of LGE at a single time point
Slice | Factor | Odds ratio and 95% CI | p value | |
---|---|---|---|---|
Presence/absence of LGE | ||||
Base (n = 105) | Native T1 | 2.1 [1.2, 3.8] | 0.012 | |
εcc | 2.6 [1.1, 6.1] | 0.034 | ||
εls | 2.3 [1.1, 4.8] | 0.032 | ||
Mid (n = 133) | Native T1 | 1.2 [0.8, 1.7] | 0.42 | |
εcc | 2.4 [1.2, 4.7] | 0.009 | ||
εls | 2.3 [1.4, 3.7] | 0.001 | ||
Apex (n = 106) | Native T1 | 1.4 [0.7, 2.8] | 0.30 | |
εcc | 1.9 [0.9, 4.1] | 0.12 | ||
εls | 1.0 [0.4, 2.6] | 0.93 | ||
Global (n = 121) | Native T1 | 1.5 [0.8, 2.6] | 0.17 | |
εcc | 2.3 [1.0, 5.1] | 0.049 | ||
εls | 2.6 [1.1, 6.0] | 0.029 | ||
Global severity score | ||||
Base (n = 104) | Native T1 | 2.2 [ 1.1, 4.6] | 0.026 | |
εcc | 3.3 [1.2, 3.3] | < 0.001 | ||
εls | 2.0 [1.9, 5.7] | 0.006 | ||
Mid (n = 132) | Native T1 | 1.3 [ 1.0, 1.9] | 0.085 | |
εcc | 2.8 [1.7, 4.6] | < 0.001 | ||
εls | 2.1 [1.5, 3.1] | < 0.001 | ||
Apex (n = 105) | Native T1 | 0.9 [ 0.6, 1.5] | 0.25 | |
εcc | 1.8 [0.9, 3.4] | 0.077 | ||
εls | 1.8 [0.9, 3.2] | 0.085 | ||
Global (n = 120) | Native T1 | 1.8 [ 1.1, 3.1] | 0.025 | |
εcc | 2.6 [1.4, 4.8] | 0.002 | ||
εls | 2.6 [1.4, 4.7] | 0.002 | ||
FWHM | ||||
Base (n = 103) | Native T1 | 1.4 [0.9, 2.2] | 0.19 | |
εcc | 2.0 [1.1, 3.5] | 0.017 | ||
εls | 1.5 [1.0, 2.2] | 0.038 | ||
Mid (n = 114) | Native T1 | 1.1 [0.8, 1.6] | 0.58 | |
εcc | 2.2 [1.3, 3.5] | 0.002 | ||
εls | 1.7 [1.1, 2.5] | 0.014 | ||
Apex (n = 103) | Native T1 | 1.0 [0.6, 1.5] | 0.85 | |
εcc | 1.3 [0.8, 2.3] | 0.26 | ||
εls | 0.9 [0.5, 1.6] | 0.70 | ||
Global (n = 119) | Native T1 | 1.3 [0.8, 2.2] | 0.28 | |
εcc | 1.4 [0.9, 2.2] | 0.19 | ||
εls | 2.0 [1.2, 3.5] | 0.01 |
Outcome condition | Model fit equation | AUC | R2 | Threshold | Sensitivity (%) | Specificity (%) | + LR | − LR |
---|---|---|---|---|---|---|---|---|
Presence/absence LGE | 0.0096 * (native T1) + 0.2263 * (ɛls) + 0.538 * (ɛcc) | 0.74 | 0.21 | 0.473 | 81.1 | 42.3 | 1.4 | 0.45 |
0.839 | 74.3 | 69.2 | 2.4 | 0.37 | ||||
1.512 | 44.6 | 96.2 | 11.7 | 0.58 | ||||
LVEF (univariate) | 0.81 | – | 56% | 56.8 | 99.9 | 568 | 0.43 | |
High (GSS 3–4) vs low (GSS 0–2) grade LGE | 0.013 * (native T1) + 0.32 * (ɛls) + 0.059 * (ɛcc) | 0.82 | 0.38 | − 1.297 | 94.9 | 53.3 | 2.0 | 0.10 |
− 0.559 | 76.9 | 76.7 | 3.3 | 0.30 | ||||
0.672 | 43.6 | 93.3 | 6.5 | 0.60 | ||||
LVEF (univariate) | 0.87 | – | 50% | 63.8 | 93.8 | 10.3 | 0.39 |
Segment | Factor | LGE presence/absence | p value |
---|---|---|---|
Odds ratio and 95% CI | |||
Basal anterior | Native T1 | 1.2 [0.9, 1.6] | 0.33 |
εcc | 1.3 [0.9, 1.9] | 0.21 | |
εls | 1.1 [0.7, 1.9] | 0.72 | |
Basal anteroseptal | Native T1 | 1.1 [0.7, 1.6] | 0.73 |
εcc | 1.4 [0.9, 2.2] | 0.17 | |
εls | 1.9 [1.2, 3.0] | 0.01 | |
Basal inferoseptal | Native T1 | 1.5 [1.1, 2.1] | 0.01 |
εcc | 3.6 [2.4, 5.5] | < 0.001 | |
εls | 1.9 [1.2, 3.0] | 0.01 | |
Basal inferior | Native T1 | 2.0 [1.2, 3.4] | 0.01 |
εcc | 2.7 [1.7, 4.1] | < 0.001 | |
εls | 1.1 [0.7, 1.6] | 0.77 | |
Basal inferolateral | Native T1 | 2.0 [1.4, 3.3] | 0.003 |
εcc | 2.9 [1.8, 4.7] | < 0.001 | |
εls | 1.4 [0.9, 2.1] | 0.21 | |
Basal anterolateral | Native T1 | 1.3 [0.8, 2.1] | 0.25 |
εcc | 4.6 [2.8, 7.7] | < 0.001 | |
εls | 1.8 [1.0, 3.3] | 0.042 | |
Mid anterior | Native T1 | 0.9 [0.6, 1.2] | 0.38 |
εcc | 2.0 [1.3, 3.2] | 0.001 | |
εls | 1.2 [0.8 1.7] | 0.38 | |
Mid anteroseptal | Native T1 | 1.0 [0.7, 1.5] | 0.99 |
εcc | 1.5 [0.9, 2.6] | 0.15 | |
εls | 1.9 [1.3, 2.8] | < 0.001 | |
Mid inferoseptal | Native T1 | 1.3 [0.8, 2.2] | 0.26 |
εcc | 3.2 [1.9, 5.6] | < 0.001 | |
εls | 1.6 [1.0, 2.4] | 0.04 | |
Mid inferior | Native T1 | 0.9 [0.5, 1.5] | 0.59 |
εcc | 2.3 [1.3, 4.1] | 0.004 | |
εls | 1.4 [1.0, 1.9] | 0.05 | |
Mid inferolateral | Native T1 | 1.4 [0.8, 2.2] | 0.25 |
εcc | 1.2 [0.5, 2.9] | 0.67 | |
εls | 2.8 [1.9, 4.3] | < 0.001 | |
Mid anterolateral | Native T1 | 0.9 [06, 1.4] | 0.59 |
εcc | 1.2 [0.5, 3.2] | 0.70 | |
εls | 1.3 [0.9, 2.0] | 0.17 |
Longitudinal assessment of LGE using native T1 and strain in individual patients
N | Mean ± SD or N (%) | |
---|---|---|
CMR 1 to CMR 2 | ||
Interval (days) | 55 | 423 ± 200 |
∆LVEF1–2 (%) | 55 | − 2.6 ± 4.7 |
Base ∆Ɛcc1–2 | 54 | 0.7 ± 3.0 |
Mid ∆Ɛcc1–2 | 55 | 0.7 ± 3.3 |
Apex ∆Ɛcc1–2 | 52 | 0.6 ± 3.4 |
∆FWHM1–2 | 37 | 4.3 ± 14.2 |
∆LGE1–2 | 53 | |
− 1 | 4 (8%) | |
0 | 31 (58%) | |
1 | 15 (28%) | |
2 | 2 (4%) | |
3 | 1 (2%) | |
CMR 2 to CMR 3 | ||
Interval (days) | 35 | 376 ± 26 |
∆LVEF2–3 (%) | 35 | − 2.4 ± 5.5 |
Base ∆Ɛcc2–3 | 34 | 0.4 ± 3.1 |
Mid ∆Ɛcc2–3 | 34 | 0.8 ± 3.1 |
Apex ∆Ɛcc2–3 | 32 | 0.1 ± 3.8 |
∆FWHM2–3 | 27 | 3.2 ± 16.3 |
∆LGE2–3 | 35 | |
− 1 | 4 (11%) | |
0 | 17 (49%) | |
1 | 11 (31%) | |
2 | 3 (9%) | |
CMR 1 to CMR 3 | ||
Interval (days) | 35 | 748 ± 344 |
∆LVEF1–3 (%) | 35 | − 5.1 ± 5.8 |
Base ∆Ɛcc1–3 | 35 | 1.2 ± 3.2 |
Mid ∆Ɛcc1–3 | 34 | 1.3 ± 3.4 |
Apex ∆Ɛcc1–3 | 34 | 0.7 ± 4.1 |
∆FWHM1–3 | 23 | 9.0 ± 16.6 |
∆LGE1–3 | 35 | |
− 1 | 2 (6%) | |
0 | 15 (43%) | |
1 | 13 (37%) | |
2 | 2 (6%) | |
3 | 3 (9%) |
Slice | Factor | Odds ratio and 95% CI | p value |
---|---|---|---|
Change in global severity score (feature tracking) | |||
Base (n = 27) | Native T1 | 1.2 [ 0.3, 5.0] | 0.78 |
εcc | 2.2 [0.6, 7.7] | 0.21 | |
εls | 1.8 [0.8, 3.9] | 0.15 | |
LGE at CMR1 | 0.6 [0.2, 1.9] | 0.37 | |
Mid (n = 30) | Native T1 | 1.2 [0.5, 2.7] | 0.64 |
εcc | 0.3 [0.1, 1.1] | 0.07 | |
εls | 3.0 [1.3, 6.7] | 0.008 | |
LGE at CMR1 | 0.3 [0.1, 1.5] | 0.13 | |
Global (n = 33) | Native T1 | 1.4 [0.6, 3.3] | 0.44 |
εcc | 0.5 [0.2, 1.2] | 0.14 | |
εls | 3.8 [ 1.0, 14.2] | 0.048 | |
LGE at CMR1 | 0.5 [0.1, 1.7] | 0.25 | |
Change in global severity score (myocardial tagging) | |||
Base (n = 42) | Native T1 | 1.3 [ 0.5, 3.2] | 0.59 |
εcc-tag | 0.8 [0.4, 1.8] | 0.56 | |
LGE at CMR1 | 0.4 [0.1, 1.3] | 0.13 | |
Mid (n = 44) | Native T1 | 1.5 [0.9, 2.4] | 0.11 |
εcc-tag | 0.6 [0.3, 1.2] | 0.15 | |
LGE at CMR1 | 0.5 [0.2, 1.6] | 0.22 | |
Global (n = 38) | Native T1 | 1.5 [0.7, 2.9] | 0.27 |
εcc-tag | 0.5 [0.2, 1.2] | 0.12 | |
LGE at CMR1 | 0.3 [0.1, 1.2] | 0.10 | |
Change in FWHM (feature tracking) | |||
Base (n = 27) | Native T1 | 1.2 [0.3, 4.8] | 0.83 |
εcc | 1.5 [0.4, 6.8] | 0.57 | |
εls | 1.9 [0.7, 4.9] | 0.19 | |
LGE at CMR1 | 0.6 [0.1, 3.7] | 0.57 | |
Mid (n = 30) | Native T1 | 0.8 [0.4, 1.6] | 0.55 |
εcc | 0.4 [0.1, 1.9] | 0.25 | |
εls | 1.5 [0.5, 4.6] | 0.48 | |
LGE at CMR1 | 0.1 [0, 1.5] | 0.10 | |
Global (n = 33) | Native T1 | 0.9 [0.4, 2.2] | 0.84 |
εcc | 0.7 [0.2, 2.7] | 0.61 | |
εls | 2.0 [0.9, 4.5] | 0.10 | |
LGE at CMR1 | 0.1 [0, 0.8] | 0.033 | |
Change in FWHM (myocardial tagging) | |||
Base (n = 36) | Native T1 | 1.7 [ 0.7, 4.1] | 0.26 |
εcc-tag | 0.6 [0.5, 0.9] | 0.003 | |
LGE at CMR1 | 0.3 [0.1, 1.6] | 0.16 | |
Mid (n = 40) | Native T1 | 1.6 [0.7, 3.8] | 0.32 |
εcc-tag | 0.4 [0.1, 0.9] | 0.036 | |
LGE at CMR1 | 0.2 [0.1, 1.1] | 0.058 | |
Global (n = 34) | Native T1 | 1.8 [0.7, 4.6] | 0.21 |
εcc-tag | 0.2 [0.1, 0.7] | 0.01 | |
LGE at CMR1 | 0.2 [0.03, 1.1] | 0.075 |
Segment | Factor | Change in severity score | p value |
---|---|---|---|
Odds ratio and 95% CI | |||
Basal anterior | Native T1 | 1.6 [1.0, 2.7] | 0.06 |
εcc | 1.4 [0.8, 2.4] | 0.30 | |
εls | 2.9 [1.2, 7.1] | 0.02 | |
Basal anteroseptal | Native T1 | 3.5 [1.6, 7.6] | 0.002 |
εcc | 1.1 [0.4, 3.1] | 0.87 | |
εls | 0.4 [0.3, 0.8] | 0.012 | |
Basal inferoseptal | Native T1 | 1.4 [1.0, 2.1] | 0.07 |
εcc | 1.1 [0.3, 1.0] | 0.55 | |
εls | 0.5 [0.3, 1.0] | 0.048 | |
Basal inferior | Native T1 | 0.5 [0.2, 1.5] | 0.23 |
εcc | 0.4 [0.1, 1.3] | 0.11 | |
εls | 2.2 [1.0, 4.9] | 0.042 | |
Basal inferolateral | Native T1 | 2.2 [0.4, 11.6] | 0.35 |
εcc | 1.1 [0.8, 1.5] | 0.11 | |
εls | 5.6 [1.1, 29.4] | 0.042 | |
Basal anterolateral | Native T1 | 1.5 [1.0, 2.2] | 0.47 |
εcc | 0.6 [0.2, 2.2] | 0.49 | |
εls | 4.0 [0.8, 20.1] | 0.10 | |
Mid anterior | Native T1 | 1.5 [0.6, 3.8] | 0.41 |
εcc | 1.6 [0.6, 4.2] | 0.37 | |
εls | 0.8 [0.5, 1.5] | 0.52 | |
Mid anteroseptal | Native T1 | 1.0 [0.9, 1.0] | 0.07 |
εcc | 0.4 [0.2, 1.1] | 0.06 | |
εls | 1.5 [0.3, 7.8] | 0.63 | |
Mid inferoseptal | Native T1 | 2.3 [0.6, 9.1] | 0.22 |
εcc | 1.1 [0.7, 1.8] | 0.55 | |
εls | 0.3 [0.1, 3.0] | 0.31 | |
Mid inferior | Native T1 | 0.4 [0.2, 0.8] | 0.006 |
εcc | 0.1 [0, 0.5] | 0.007 | |
εls | 2.4 [0.8, 7.1] | 0.13 | |
Mid inferolateral | Native T1 | 2.9 [1.1, 8.3] | 0.042 |
εcc | 0.5 [0.1, 2.0] | 0.33 | |
εls | 1.8 [0.4, 9.2] | 0.48 | |
Mid anterolateral | Native T1 | 1.2 [0.7, 2.1] | 0.46 |
εcc | 0.9 [0.7, 1.1] | 0.34 | |
εls | 1.7 [0.4, 7.5] | 0.45 |